Théraclion SA develops, manufactures, and markets oncological medical equipment. Its products are marketed under the brands of Sonovein, EchoPulse and EPack. EchoPulse is a device used for non-invasive and outpatient treatment of fibroadenoma of the breast and thyroid nodules. EPack is a single-use disposable patented system used for cooling and coupling functions. The company was founded by François Lacoste and Jérôme Lebon on August 5, 2004 and is headquartered in Malakoff, France.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company